Sellas Life Sciences Group Inc
NASDAQ:SLS

Watchlist Manager
Sellas Life Sciences Group Inc Logo
Sellas Life Sciences Group Inc
NASDAQ:SLS
Watchlist
Price: 4.51 USD -1.53% Market Closed
Market Cap: 642.4m USD

Intrinsic Value

The intrinsic value of one SLS stock under the Base Case scenario is 1.24 USD. Compared to the current market price of 4.51 USD, Sellas Life Sciences Group Inc is Overvalued by 72%.

SLS Intrinsic Value
1.24 USD
Overvaluation 72%
Intrinsic Value
Price
Base Case Scenario

Valuation History
Sellas Life Sciences Group Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about SLS?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is SLS valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Sellas Life Sciences Group Inc.

Explain Valuation
Compare SLS to
Custom
Choose any stock to compare

Fundamental Analysis

SLS Profitability Score
Profitability Due Diligence

Loading...
Loading...
Loading...
Loading...
Profitability
Score

SLS Solvency Score
Solvency Due Diligence

Loading...
Loading...
Loading...
Loading...
Solvency
Score
Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about SLS?
Bearish
Neutral
Bullish
Efficiency

Free Cash Flow Analysis
Sellas Life Sciences Group Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Sellas Life Sciences Group Inc

Wall St
Price Targets

SLS Price Targets Summary
Sellas Life Sciences Group Inc

Wall Street analysts forecast SLS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SLS is 6.97 USD with a low forecast of 6.06 USD and a high forecast of 7.88 USD.

Lowest
Price Target
6.06 USD
34% Upside
Average
Price Target
6.97 USD
55% Upside
Highest
Price Target
7.88 USD
75% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Sellas Life Sciences Group Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for SLS is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

SLS Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one SLS stock?

The intrinsic value of one SLS stock under the Base Case scenario is 1.24 USD.

Is SLS stock undervalued or overvalued?

Compared to the current market price of 4.51 USD, Sellas Life Sciences Group Inc is Overvalued by 72%.

Back to Top